期刊文献+

白细胞介素-33及其受体ST2在寻常型银屑病皮损中的表达 被引量:4

Expression of interleukin-33 and its receptor ST2 in psoriasis vulgaris
下载PDF
导出
摘要 目的研究白细胞介素-33(IL-33)及其受体ST2在寻常型银屑病(PV)皮损中的表达情况。方法选取PV患者30例(PV组)和非PV患者15例(正常对照组)为研究对象,取PV组患者的皮损区和正常对照组患者的正常皮肤采用免疫组织化学和免疫荧光法检测IL-33和ST2的表达水平。结果与正常对照组比较,PV组患者皮损组织中IL-33及其受体ST2从表皮细胞的基底层到颗粒层均存在高表达。IL-33在PV组患者的阳性表达率为90.00%,高于正常对照组的阳性表达率46.67%(P<0.05)。ST2在PV组阳性表达率为83.33%,高于正常对照组的阳性表达率53.33%(P<0.05)。结论 IL-33及其受体ST2在PV皮损中表达显著增高,提示IL-33和ST2可能在PV的发生发展中发挥着重要的作用。 Objective To study the expression of interleukin-33 (IL-33) and its receptor ST2 in psoriasis vulgaris (PV) lesions. Methods Thirty PV patients (PV group) and fifteen non-PV patients (normal control group) were selected as study subject. Tissue samples from lesion area of patients in PV group and normal skin of patients in normal control group were obtained to detect the expression levels of IL-33 and ST2 by using immunohistochemistry and immunofluorescence methods. Results Compared with the normal control group,the expression of IL-33 and ST2 in lesion area(from the basal layer of the epidermis to the granular layer) of patients in PV group was higher. The positive expression rate of IL-33 and ST2 in PV group was 90.00% and 83.33% ;the positive expression rate of IL-33 and ST2 in normal control group was 46.67% and 53.33% ; the positive expression rate of IL-33 and ST2 in PV group was significantly higher than that in normal control group (P 〈 0. 05 ). Conclusion The lesion area of PV patients has higher expression of IL-33 and its receptor ST2, which suggesting that IL-33 and ST2 may play important roles in the development of PV.
出处 《新乡医学院学报》 CAS 2016年第9期780-782,共3页 Journal of Xinxiang Medical University
基金 河南省教育厅科学技术研究重点项目(编号:13A320852) 河南省医学科技攻关项目(编号:201502016) 河南省中青年卫生科技创新型人才工程专项基金(编号:201004159)
关键词 寻常型银屑病 白细胞介素-33 ST2 免疫组织化学 免疫荧光 psoriasis vulgaris interleukin-33 ST2 immunohistochemistry immunofluorescence
  • 相关文献

参考文献15

  • 1ENAMANDRAM M,KIMBALL A B. Psoriasis epidemiology: the interplay of genes and the environment[ J]. Invest Dermato1,2013, 133(2) :287-289.
  • 2LOWES M A,SUAREZ-FARINAS M, KRUEGER J G. Immunology of psoriasis[ J]. Annu Rev Immunol,2014,32( 1 ) :227-255.
  • 3SCHMITZ J, OWYANG A, OLDHAM E,et al. IL-33, an interleu- kin-l-like cytokine that signals via the IL-1 receptor-related pro- tein ST2 and induces T helper type 2-associated cytokines[ J ]. Im- munity,2005,23 ( 5 ) :479-490.
  • 4李萍萍,吴京,马明,于健,王博.白细胞介素-33在大鼠角膜移植免疫排斥反应中的作用[J].眼科新进展,2015,35(6):516-519. 被引量:1
  • 5LIEW F Y,PITMAN N I, MCLNNES I B. Disease-associated func- tion of IL-33:the new kid in the IL-I family[J]. Nat Rev lmmu- no1,2010,10(2) : 103-111.
  • 6MARTIN N T,MARTIN M U. Intedeukin 33 is a guardian of barri- ers and a local alarmin[J]. Nat Immalnol,2016,17(2) :122-131.
  • 7岳佳,韩子明,韩玫瑰,黄倩,张芳敏.过敏性紫癜性肾炎患儿血清白细胞介素-33和T细胞免疫球蛋白域黏蛋白域蛋白-1的表达及临床意义[J].新乡医学院学报,2015,32(7):653-656. 被引量:16
  • 8MILLER A M, LIEW F Y. The IL-33/ST2 pathway : a new thera- peutic target in cardiovascular disease[J]. Pharmacol Ther,2011, 131 (2) :179-186.
  • 9BARBOUR M,ALLAN D,XU H,et al. IL-33 attenuates the devel- opment of experimental autoimmune uveitis [ J ]. Eur J Immunol, 2014,44( 11 ) :3320-3329.
  • 10JAFARZADEH A, MAHDAVI R, JAMALI M, et al. Increased concentrations of interleukin-33 in the serum and cerebrospinal fluid of patients with multiple sclerosis[ J ]. Oman Med J,2016, 31 ( 1 ) :40-45.

二级参考文献69

  • 1许自川,曾雪琪,党西强,何小解.Th1/Th2迁移与紫癜性肾炎的研究进展[J].国际病理科学与临床杂志,2007,27(1):64-67. 被引量:15
  • 2Miller AM. Role of IL-33 in inflammation and disease[J]. J Inflamm (Lond), 2011,8(1) : 22 -36.
  • 3Onda H, Kasuya H, Takakura K, et al. Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemor-rhage [ J ]. J Cereb Blood Flow Metab, 1999, 19(11) : 1279 -1288.
  • 4Baekkevold ES, Roussign6 M, Yamanaka T, et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules[ J]. Am J Pathol, 2003, 163 ( 1 ) : 69 - 79.
  • 5Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1- like cytokine that signals v/a the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines [ J ]. Immunity, 2005, 23 (5) : 479 - 490.
  • 6Mirchandani AS, Salmond RJ, Liew FY. Interleukin-33 and the function of innate lymphoid cells [ J]. Trends Immunol, 2012, 33 ( 8 ) : 389 - 396.
  • 7Tominaga S. A putative protein of a growth specific eDNA from BALB/c 313 cells is highly similar to the extracellular portion of mouse interleukin I receptor [ J]. FEBS Lett, 1989, 258 (2) : 301 - 304.
  • 8Liew FY, Pitman NI, Mclnnes lB. Disease-associated function of ID33: the new kid in the IL-1 family[J]. Nat Rev Immunol, 2010, 10(2) : 103 -111.
  • 9Miller AM, Liew FY. The IL-33/ST2 pathway-A new therapeutic target in cardiovascular disease [ J]. Pharmacol Ther, 2011, 131(2) : 179 -186.
  • 10Nakae S, Morita H, Ohno T, et al. Role of interleukin-33 in innate-type immune cells in allergy [ J ]. Allergol hat, 2013, 62 (1) : 13 -20.

共引文献21

同被引文献29

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部